Lupin Q2 beats forecast, net up 12% to Rs 290 cr

Pharmaceutical firm Lupin  's net profit rose by 12 percent year-on-year to Rs 290 crore in the quarter ended September 2012.

Net sales grew by higher-than-expected 29 percent YoY to Rs 2,239 crore during the same period.

Analysts on an average had estimated a net profit of Rs 279.3 crore on net sales of Rs 2,200 crore for the quarter.

Earnings before interest, tax, depreciation and amortization (EBITDA) increased 28 percent YoY to Rs 520 crore in the July-September quarter of 2012, which was above expectations of Rs 430 crore.

But EBITDA margin declined marginally to 22.4 percent versus 22.8 percent during the same period. Analysts had forecast of 19.5 percent.

At 14:10 hours IST, the share rose 0.6 percent to Rs 573.20 on the Bombay Stock Exchange.

 

Source: www.moneycontrol.com

Thanks,

Gaurav Agarwal 

Head Dealer 

DENIP Consultants Pvt Ltd